

Cover Story
COVID-19 & CancerGuest Editorial
By Jeremy L. Warner and Sanjay Mishra
As we head into the third year of the global COVID-19 pandemic, everyone would just like it to be over.
COVID-19 & Cancer
By Matthew Bin Han Ong, Alexandria Carolan and Alice Tracey
In Brief


Clinical Roundup


Drugs & Targets
Trending Stories
- Two lawsuits vs. Tempus raise questions about privacy of germline data in cancer RWE
“Deidentified” ≠ “deidentifiable” - Mail-out colorectal cancer screening programs extend, rather than replace, clinical care
- Lou Weiner to step down as director of Georgetown’s Lombardi CCC after 18 years
- After a year, Stephenson institute sees a broader role in funding pancreatic cancer research, fostering collaborations
“We are not just funding research. We are building a trusted community.” - Trump administration announces “major crackdown” on healthcare fraud
- FDA issues draft guidance on accelerating development of individualized therapies for ultra-rare diseases















